Darya Rose

Darya Rose is a seasoned market access strategy professional with a rich background in the life sciences industry, boasting 15 years of experience. She holds a robust knowledge base in US managed care and health technology assessment within the EU markets.

In her current capacity, Darya excels in steering the development of payer strategies and tactical plans aimed at effectively articulating product value to key decision-makers in population health. Her prior role involved serving as a healthcare strategy consultant, where she spearheaded various projects catering to both established and emerging biopharmaceutical entities.

Darya's consulting experience includes crafting value propositions for product launches, conducting primary payer research, evaluating reimbursement landscapes, devising evidence generation strategies, developing health economic models, and assembling formulary dossiers. She boasts a broad spectrum of expertise across multiple therapeutic areas like infectious diseases, oncology, CNS disorders, and inflammatory conditions.